- Dynavax Technologies Corporation is a commercial-stage biopharmaceutical company specializing in innovative vaccines, notably HEPLISAV-B, the first two-dose adult Hepatitis B vaccine, positioning itself as a leader in the adult vaccine market.
- In December 2025, Dynavax announced its acquisition by Sanofi for approximately $2.2 billion, following a successful pivot from research-heavy operations to a commercially viable entity with significant revenue growth.
- Dynavax's HEPLISAV-B vaccine has generated record net product revenue of $65 million in Q1 2025, reflecting a 36% year-over-year increase, and the company is advancing its pipeline with new vaccine programs for shingles and Lyme disease.
- The ideal buyer for Dynavax's products includes healthcare providers and pharmaceutical companies seeking to enhance their vaccine portfolios, addressing the critical need for effective adult vaccination solutions in a rapidly evolving healthcare landscape.
Sales and Support is the largest team at Dynavax Technologies, accounting for about 39 % of employees (108 people) and underscoring the company’s emphasis on customer engagement and product distribution. Core scientific work is handled by 36 Engineering professionals, while Business Management (29) and Finance & Administration (28) provide operational backbone. Additional groups such as Operations (16), Marketing & Product (14), Healthcare professionals (11), Risk, Safety & Compliance (8), and Information Technology (7) round out a diversified departmental mix. An “Other” category holding 18 employees reflects roles that do not fit neatly into the standard departments, giving Dynavax flexibility in staffing specialized positions.
Dynavax maintains a distributed workforce: 62 employees are based in San Francisco, its largest identifiable hub, while 169 staff members work in various other locations that are not tied to a single office, suggesting a sizable remote or field-based contingent. The remaining team is spread across several U.S. cities, including Washington DC (9), New York (8), Tampa (6), Boston (5), Philadelphia (5), Minneapolis (4), Charlotte (4), and Houston (3). This geographic dispersion supports nationwide commercial operations and provides access to diverse talent pools.
